Solventum (SOLV) return on equity (ROE)

Return on equity · fiscal 2025
30.8%

Solventum (SOLV) earned a return on equity of 30.8% in fiscal 2025 (the year ended December 31, 2025). That is 14.6 percentage points higher than the 16.2% of fiscal 2024. Figures as of 17 Nov 2026, 22:40 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2025
30.8%
Change on fiscal 2024
+14.6 pts
Highest on record
30.8%fiscal 2025
Lowest on record
11.4%fiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Solventum return on equity (ROE), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 30.8% in fiscal 2025 and the lowest 11.4% in fiscal 2022. The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 11.5%.

History · 4 fiscal years

Return on equity by fiscal year

Solventum return on equity (ROE), year by year

Solventum (SOLV) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202530.8% 14.6 pts up
202416.2% 4.7 pts up
202311.5% 0.1 pts up
202211.4%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Solventum and comparable companies
CompanyReturn on equityFiscal year
Ascendis Pharma ASND-221.5%2022
ICON ICLR2.5%2025
Jazz Pharmaceuticals JAZZ-8.2%2025
Solventum SOLV30.8%2025
BridgeBio Pharma BBIO-872.9%2020
Summit Therapeutics SMMT-163.9%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SOLV

Solventum, figure by figure

Solventum (SOLV) overview: price, valuation and scorecardAll health care companies by market value

Solventum return on equity (ROE): questions and answers

What is Solventum's return on equity?

Solventum (SOLV) earned a return on equity of 30.8% in fiscal 2025 (the year ended December 31, 2025). That is 14.6 percentage points higher than the 16.2% of fiscal 2024.

Is Solventum's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in every one of the 3 earlier fiscal years on record, whose median is 11.5%.

What are the highest and lowest return on equity figures on record for Solventum?

Across the 4 fiscal years on record (2022–2025), the highest was 30.8% in fiscal 2025 and the lowest 11.4% in fiscal 2022.

How is Solventum's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Solventum (SOLV) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/SOLV/roe

Underlying data: Yahoo Finance.